Yale University

Publications

Filters: Keyword is Hepacivirus  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
B
Bruce, Douglas R., Julie Eiserman, Angela Acosta, Ceilia Gote, Joseph K. Lim, and Frederick L. Altice. "Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication." The American journal of drug and alcohol abuse 38, no. 3 (2012): 206-12. Abstract
F
Fultz, Shawn L., Amy C. Justice, Adeel A. Butt, Linda Rabeneck, Sharon Weissman, and Maria Rodriguez-Barradas. "Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 36, no. 8 (2003): 1039-46. Abstract
G
Gordon, Stuart C., Andrew J. Muir, Joseph K. Lim, Brian Pearlman, Curtis K. Argo, Ananthakrishnan Ramani, Benedict Maliakkal, Imtiaz Alam, Thomas G. Stewart, Monika Vainorius et al. "Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET." Journal of hepatology 62, no. 2 (2015): 286-93. Abstract
H
Hagan, Holly, Enrique R. Pouget, Ian T. Williams, Richard L. Garfein, Steffanie A. Strathdee, Sharon M. Hudson, Mary H. Latka, and Lawrence J. Ouellet. "Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities." The Journal of infectious diseases 201, no. 3 (2010): 378-85. Abstract
Heimer, R., K. Khoshnood, B. Jariwala-Freeman, B. Duncan, and Y. Harima. "Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens." The Journal of infectious diseases 173, no. 4 (1996): 997-1000. Abstract
Huik, Kristi, Maarja Sadam, Tõnis Karki, Radko Avi, Tõnu Krispin, Piret Paap, Kristi Rüütel, Anneli Uusküla, Ave Talu, Katri Abel-Ollo et al. "CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users." The Journal of infectious diseases 201, no. 5 (2010): 730-9. Abstract
L
Lelutiu-Weinberger, Corina, Enrique R. Pouget, Don D. C. Des Jarlais, Hannah L. Cooper, Roberta Scheinmann, Rebecca Stern, Shiela M. Strauss, and Holly Hagan. "A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups." Social science & medicine (1982) 68, no. 3 (2009): 579-90. Abstract
P
Paintsil, Elijah, Sergei V. Verevochkin, Elena Dukhovlinova, Linda Niccolai, Russell Barbour, Edward White, Olga V. Toussova, Louis Alexander, Andrei P. Kozlov, and Robert Heimer. "Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection." Addiction (Abingdon, England) 104, no. 11 (2009): 1881-90. Abstract
Pol, Stanislas, Reem H. Ghalib, Vinod K. Rustgi, Claudia Martorell, Greg T. Everson, Harvey A. Tatum, Christophe Hézode, Joseph K. Lim, Jean-Pierre Bronowicki, Gary A. Abrams et al. "Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial." The Lancet infectious diseases 12, no. 9 (2012): 671-7. Abstract
U
Uusküla, Anneli, Louise Anne McNutt, Jack Dehovitz, Krista Fischer, and Robert Heimer. "High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia." International journal of STD & AIDS 18, no. 1 (2007): 41-6. Abstract
Uuskula, Anneli, Robert Heimer, Jack Dehovitz, Krista Fischer, and Louise-Anne McNutt. "Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance." The Journal of infectious diseases 193, no. 3 (2006): 455-7. Abstract